Page 385 - medicina-integrativa_compress

386 PARTE II, SECCIÓN 6 TRASTORNOS METABÓLICOS Y ENDOCRINOS

Vanadil-sulfato, 2,5 a 10 mg/día. Ginseng americano, 1 g antes de las comidas
B B 2 2 cada 8 h. B B 2 2
Picolinato de cromo, 200 a 1.000 μg/día.
®
B B 2 2 Metformina (Glucophage ), 500 a 2.500 mg
L-arginina, 500 a 2.000 mg/día, cada mañana o cada 12 h. A A 2 2
administrados con el estómago vacío.
C 2 2
Rosiglitazona (Avandia ), de 2 a 4 g cada
®
mañana o pioglitazona (Actos ), 15 a A A 2 2
®
■ Fitoterapia/fármacos 45 mg cada mañana.
Los individuos con riesgo elevado pueden
tratarse más apropiadamente con un
fitofármaco o un fármaco.

14. Mokdad AH, Ford ES, Bowman BA, et al: Prevalence of obesity,
Dado que la RI es un proceso continuo que va desde un diabetes, and obesity-related health risk factors, 2001. JAMA
diagnóstico de laboratorio hasta el síndrome metabólico y 289:76-79, 2003.
la DM-2, es necesario tratar el problema específico de cada 15. Hu FB, Li TY, Colditz GA, et al: Television watching and other
paciente. A medida que avanza la enfermedad, están sedentary behaviors in relation to risk of obesity and type 2 diabetes
indicadas más intervenciones terapéuticas. Incluso el 16. mellitus in women. JAMA 289:1785-1791, 2003.
The Diabetes Prevention Program: Design and methods for a clinical
paciente que consigue realizar los cambios con éxito deberá trial in the prevention of type 2 diabetes. Diabetes Care 22:623-634,
vigilarse de por vida, con apoyo emocional y médico 1999.
constante. Son apropiadas las determinaciones periódicas 17. Surwit RS, van Tilburg MA, Zucker N, et al: Stress management
de los indicadores de laboratorio de inflamación, lípidos, improves long-term glycemic control in type 2 diabetes. Diabetes
glucemia, insulina, etc. Care 25:30-34, 2002.
18. Bland J: personal communication, 1996.
19. Knoops KT, de Groot LC, Kromhout D, et al: Mediterranean diet,
lifestyle factors, and 10-year mortality in elderly European men and
women: The HALE project. JAMA 292:1433-1439, 2004.
20. Esposito K, Marfella R, Ciotola M, et al: Effect of a Mediterranean-
BIBLIOGRAFÍA
style diet on endothelial dysfunction and markers of vascular
1. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic inflammation in the metabolic syndrome: A randomized trial.
syndrome among US adults: Findings from the third National Health JAMA 292:1440-1446, 2004.
and Nutrition Examination Survey. JAMA 287:356-359, 2002. 21. Anderson JW, Allgood LD, Turner J, et al: Effects of psyllium on
2. Erkelens DW: Insulin resistance syndrome and type 2 diabetes glucose and serum lipid responses in men with type 2 diabetes and
mellitus. Am J Cardiol 88:38J-42J, 2001. hypercholesterolemia. Am J Clin Nutr 70:466-473, 1999.
3. Meigs J, MD: Personal communication. 22. Mori TA, Bao DQ, Burke V, et al: Dietary fish as a major component
4. 41st Annual Meeting, European Association for the Study of of a weight-loss diet: Effect on serum lipids, glucose, and insulin
Diabetes, September 12-15, 2005, Athens. metabolism in overweight hypertensive subjects. Am J Clin Nutr
5. Executive Summary of the Third Report of the National Cholesterol 70:817-825, 1999.
Education Program (NCEP) Expert Panel on Detection, Evaluation, 23. Paolisso G, Sgambato S, Gambardella A, et al: Daily magnesium
and Treatment of High Blood Cholesterol in Adults (Adult supplements improve glucose handling in elderly subjects. Am J
Treatment Panel III). JAMA 285:2486-2497, 2001. Clin Nutr 55:1161-1167, 1992.
6. Makimattila S, Virkamaki A, Groop PH, et al: Chronic 24. Evans GW, Bowman TD: Chromium picolinate increases
hyperglycemia impairs endothelial function and insulin sensitivity membrane fluidity and rate of insulin internalization. J Inorg
via different mechanisms in insulin-dependent diabetes mellitus. Biochem 46:243-250, 1992.
Circulation 94:1276-1282, 1996. 25. French RJ, Jones PJ: Role of vanadium in nutrition: Metabolism,
7. Janssen I, Katzmarzyk PT, Ross R: Body mass index, waist essentiality and dietary considerations. Life Sci 52:339-346, 1993.
circumference, and health risk: Evidence in support of 26. Schulman SP, Becker LC, Kass DA, et al: L-Arginine therapy in acute
current National Institutes of Health guidelines. Arch Intern myocardial infarction: The Vascular Interaction with Age in
Med 162:2074-2079, 2002. Myocardial Infarction (VINTAGE MI) randomized clinical trial.
8. Folsom AR, Pankow JS, Tracy RP, et al: Association of C-reactive JAMA 295:58-65, 2006.
protein with markers of prevalent atherosclerotic disease. Am J 27. Evans J, Goldfine B: Are oxidative stress-activated signaling
Cardiol 88:112-117, 2001. pathways mediators of insulin resistance and beta-cell dysfunction?
9. Hay LL: Heat Your Body. Carlsbad, Calif. Hay House, 1984. Diabetes 52:1-8, 2003.
10. Proceedings of the American College of Endocrinology Insulin 28. Barringer TA, Kirk JK, Santaniello AC, et al: Effect of a multivitamin
Resistance Syndrome Conference. Washington, DC, USA. and mineral supplement on infection and quality of life: A
August 25-26, 2002. Endocr Pract 9(Suppl 2):22-112, 2003. randomized, double-blind, placebo-controlled trial. Ann Intern Med
11. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes 138:365-371, 2003.
Prevention Program Research Group: Reduction in the incidence of
type 2 diabetes with lifestyle intervention or metformin. N Engl J
Med 346:393-403, 2002. BIBLIOGRAFÍA RECOMENDADA
12. Schneider SH, Khachaduvian AK, Amorosa LF, et al: Ten-year
experience with an exercise-based at patient life-style modification Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined
program in the treatment of diabetes mellitus. Diabetes Care metabolic syndrome, diabetes, and prevalence of coronary heart
15:1800-1810, 1992. disease among NHANES III participants age 50 years and older.
13. Henry RR, Scheaffer L, Olefsky JM: Glycemic effects of intensive Diabetes 52:1210-1214, 2003.
caloric restriction and isocaloric refeeding in noninsulin-dependent American Diabetes Association: Screening for type 2 diabetes. Diabetes
diabetes mellitus. J Clin Endocrinol Metab 61:917-925, 1985. Care 27(Suppl 1):11-14, 2004.